Evidence map›Paper›PMID 40801004›Full record

ArticleAfrican journal of laboratory medicine2025

Molecular identification and antifungal susceptibility testing of

Adeyinka A Davies, Bram Spruijtenburg, Eelco F J Meijer, Iriagbonse I Osaigbovo, Oluwaseyi Balogun, Abiola Adekoya, Titilola Gbaja-Biamila, Jacques F Meis, Rita Oladele

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African journal of laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adeyinka A DaviesDepartment of Medical Microbiology and Parasitology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.ORCID https://orcid.org/0000-0002-6849-1315
Bram SpruijtenburgDepartment of Medical Microbiology and Immunology, Canisius-Wilhelmina Hospital (CWZ)/Dicoon, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-6734-361X
Eelco F J MeijerDepartment of Medical Microbiology and Immunology, Canisius-Wilhelmina Hospital (CWZ)/Dicoon, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-0226-024X
Iriagbonse I OsaigbovoDepartment of Medical Microbiology, School of Medicine, University of Benin, Benin City, Nigeria.ORCID https://orcid.org/0000-0001-8111-0743
Oluwaseyi BalogunDepartment of Biomedical Engineering, University of Lagos, Idi-Araba, Surulere, Nigeria.ORCID https://orcid.org/0000-0002-7329-8448
Abiola AdekoyaDepartment of Radiology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.ORCID https://orcid.org/0000-0001-7772-6027
Titilola Gbaja-BiamilaNigeria Institute of Medical Research, Yaba, Lagos, Nigeria.ORCID https://orcid.org/0000-0003-2958-2924
Jacques F MeisRadboudumc-CWZ Center of Expertise for Mycology, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0003-3253-6080
Rita OladeleDepartment of Medical Microbiology and Parasitology, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.ORCID https://orcid.org/0000-0003-1488-3345

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Triazole resistance in Objective: This study aimed to confirm the identity of Methods: This study examined 47 Results: The 51 patients who met the diagnostic criteria for CPA included 30 (59.0%) male and 21 (41.0%) female patients (age range: 17-68 years). Thirty-six (71.0%) had positive Conclusion: Clinical What this study adds: This study underscores the importance of routine surveillance for antifungal resistance to detect the occurrence of resistance strains early in clinical settings, as this has therapeutic implications for patients harbouring resistant phenotypes.

Indexed as

antifungal susceptibility testAspergillus spp.chronic pulmonary aspergillosisNigeriaphylogenetic analysistuberculosis

Identifiers

PMID40801004
PMCPMC12339882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.